Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir

Information

  • Patent Grant
  • 12090087
  • Patent Number
    12,090,087
  • Date Filed
    Friday, April 16, 2021
    3 years ago
  • Date Issued
    Tuesday, September 17, 2024
    2 months ago
  • Inventors
  • Original Assignees
    • Bausch + Lomb Ireland Limited
  • Examiners
    • Hashimi; Sarah Al
    • Chatrathi; Arjuna P
    Agents
    • Greenberg Traurig, LLP
    • Pham; Chinh H.
    • Cull; Andrew
Abstract
Multi-dose preservative-free ocular fluid delivery devices are provided. The fluid delivery device includes a fluid dispensing system and a fluid package for storing a liquid therein and supplying said liquid to the dispensing system. The dispensing system comprises an elongated chamber which includes a check valve which defines a frontal closure to the chamber. The valve is normally closed and hermetically seals the chamber. The dispenser includes a vibration motor that induces oscillations to the chamber and to the fluid within. The oscillations of the chamber impart momentum to the fluid stored in the chamber which in turn imparts force that cyclically opens the valve to dispense streams or liquid droplets. Fluid is dispensed only when the motor oscillates while otherwise the valve is hermetically closed. The fluid package can be made collapsible to remove the need to vent it.
Description
FIELD OF THE INVENTION

The present invention generally pertains to devices for dispensing fluid medicines and more particularly pertains to such devices that store and deliver ophthalmic preservative-free medicines, specifically configured to increase the ease of use and enhance patient compliance with dosing instructions for the medicine.


BACKGROUND

Ease of dispensing fluid medicines and compliance with dosing instructions are primary concerns with all patients. In particular, preservative-free dispensing bottles such as ophthalmic squeeze dispensers typically require greater actuation force due to a valve mechanism that seals the dispensing nozzle to prevent bacterial ingress and contamination. Such system requires much higher pressure to operate and hence much higher squeeze force is required. In addition, prior art dispensing bottles dispense only in an upside-down orientation which require an inconvenient head maneuver and which together with higher actuation force further increases the inconvenience.


Dispensers of the kind in question are known from the prior art, for example from U.S. Pat. Nos. 6,095,376, 9,676,525, US 2014/0336596, US 2016/0107180, U.S. Pat. Nos. 9,238,532, 8,056,766, 8,863,998, and 10,105,720. The dispenser shown in US 2014/0336596 comprises an outlet channel which connects the liquid reservoir to the outlet opening through an outlet valve which is arranged in the outlet channel and which opens when the bottle is squeezed and pressure is generated. Such preservative-free squeeze bottles typically require about 25-28N of squeeze force (Ophthalmic Squeeze Dispenser—Drug Development and Delivery October 2017 Vol. 17 No. 7 page 40). Elderly patients, or other patients lacking enough strength and/or dexterity in their hands, often experience problems dispensing medicine from such bottles.


This work provides preservative free ocular dispensing device that can be held horizontally, or in any convenient orientation while the actuation is done effortlessly by an electrical switch. This provides a cost effective solution that is consistent with standard drug packaging processes.


The fluid reservoir can be made collapsible to remove the need to vent it.


SUMMARY

Multi-dose preservative-free ocular fluid delivery devices are provided. The fluid delivery device includes a fluid dispensing system and a fluid package for storing a liquid therein and supplying said liquid to the dispensing system. The dispensing system comprises an elongated chamber which includes a check valve which defines a frontal closure to the chamber. The valve is normally closed and hermetically seals the chamber. In this work the chamber includes a vibration motor that induces oscillations to the chamber and to the fluid within. The oscillations of the chamber impart momentum to the fluid stored in the chamber which in turn imparts force that cyclically opens the valve to dispense streams or liquid droplets. Fluid is dispensed only when the motor oscillates while otherwise the valve is hermetically closed.


The check valve can include a flexible plate which includes a conical aperture that extends through its thickness, the valve can further include a stationary spherical member that engages tangentially with the inner wall of the conical aperture to create a hermetic sealed closure. The plate can be made of elastomer that has a modulus of elasticity ranging between 0.1-1.2 GPa. The circumference of the plate can be attached to the chamber by a retaining ring that engages with the chamber in an interference fit to create the hermetically sealed closure.


The conical aperture extends through the thickness of the plate such that droplets are dispensed through the smaller opening of the aperture while the larger side of the aperture is in fluid communication with the chamber.


The spherical member may include an antibacterial coating which covers the area of the spherical member that is between the tangential engagement line and the small opening of the aperture.


The vibrational motor oscillates the chamber and the fluid within the chamber. Consequently, cycles of hydrodynamic pulses are generated causing the valve to cyclically open and dispense fluid. Here this phenomenon is characterized by oscillatory interactions between the valve and the surrounding fluid. The hydrodynamic force generated by the momentum of the fluid opens the valve and allows fluid flow through the aperture.


Fluid is dispensed only when the hydrodynamic force is sufficiently high to deform the aperture while otherwise the aperture hermetically seals the chamber. The system prevents ingress of microorganism into the chamber allowing storage of preservative free pharmaceutical. This work provides an electrically operated preservative-free dispensing system that is convenient and cost effective.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a cross sectional view of an embodiment of the invention.



FIG. 1B is a detail cross sectional view of the embodiment of FIG. 1A.



FIG. 1C is a 3D view of the embodiment of FIGS. 1A-B.



FIG. 2A is a side view and partial cross section view of an embodiment of the invention in operation.



FIG. 2B is a detail cross section view of the example of FIG. 2A.



FIG. 3 illustrates a perspective view of a vibration motor as used in embodiments of the invention.



FIG. 4A is a frontal view of an embodiment of the invention.



FIG. 4B is a side view of the embodiment of FIG. 4A.



FIG. 4C is a detail cross sectional view of the embodiment of FIG. 4A.



FIG. 5A is a frontal view of an exemplary device enclosed in a housing.



FIG. 5B is a side view of the example of FIG. 5A.



FIGS. 6A-B are perspective views of a device having a housing that includes a swivel cover.



FIGS. 7A-B shown another embodiment of the invention.



FIGS. 8A-B are cross section views of the example of FIGS. 7A-B





DETAILED DESCRIPTION

This work describes dispensing devices and methods for delivery of preservative-free solutions or suspensions for ocular administration of ophthalmic drugs. The dispensing devices include a droplet ejecting system that is fluidly connected to an ampoule package containing a liquid to be dispensed. The droplet ejecting system includes a chamber having a check valve that defines a front closure to the chamber. The dispensing system further includes a vibration motor that oscillates the chamber and induces hydrodynamic pulses which consequently causes the valve to cyclically open and eject fluid droplets. The valve is normally closed and hermetically sealing the chamber. The valve opens exclusively in response to hydrodynamic pulses induced by the oscillation of the chamber. In this way fluid is dispensed only when the device is actuated while otherwise the aperture hermetically seals the device and prevents ingress of bacterial and microorganisms thereby allowing storage of preservative-free pharmaceutical formulation. The use of a vibration motor further enables convenient and cost effective, electronically controlled administration.



FIG. 1A and FIG. 1B illustrate a side view and an enlarged partial section view, respectively, of a fluid delivery device 100. Delivery device 100 includes a fluid reservoir 102 and dispensing system 104 connected to each other in fluid transmission relationship though passage 106. Dispensing system 104 includes a fluid chamber 108 and also includes a check valve including aperture plate 110 which provides frontal closure to the chamber 108. Referring to FIG. 1B it can be seen that aperture plate 110 includes a conical or tapered aperture 116 (shown inside a dotted circle for clarity) that extends through its center thickness and has a large inlet opening 116a in fluid communication with chamber 108 and a smaller exit opening 116b though which fluid droplets will be dispensed. Aperture plate 110 can be made of a flexible elastomer such as silicone rubber, VersaFlex, manufactured by VersaFlex Incorporated Kansas City, Kansas USA. Other elastomers with Young modulus of elasticity value between 0.5 GPa to 2 GPa can also be used. Dispensing system 104 further includes a stationary spherical member 114 that tangentially engages in pressure transmission relationship with the inlet opening 116a of the conical aperture providing hermetically sealed closure. In a preferred embodiment spherical member 114 is made of high density polyethylene (HDPE) that is harder than silicone thereby creating a tight closure as it engages with the softer aperture plate 110. Spherical member 114 preferably engages in pressure transmission relationship with the conical aperture 116a with a preload force of between 0.01N and 0.05N. The combination of aperture plate 110 and spherical member 114 provides a check valve as described above. Spherical member 114 is supported by pin member 112. Member 114 can have a shape other than spherical, since any shape capable of forming a good seal with aperture plate 110 can be used.


Aperture plate 110 can be retained to dispensing system 104 by a retaining ring 130, thereby creating a hermetically sealed closure.


Dispensing system 100 includes a venting tube 126 that is configured to equalize the pressure inside container 102 as the fluid is dispensed from the device. The opening 134 of venting tube 126 is extended above the fluid level 132 at any orientation that the device is held. Vent tube 126 can be connected via a 0.22 micron filter 128 to assure that the air that enters the device is sterile.


Dispensing system 100 further includes a vibration motor configured to oscillate chamber 108 and the fluid within the chamber. Here this motor is schematically shown as eccentric mechanical load 118 which vibrates the assembly as described when it is rotated by the motor (motor not shown in FIGS. 1A-B, but described below in connection with FIG. 3).



FIG. 1C is a 3D view of the embodiment of FIGS. 1A-B.



FIGS. 2A-B illustrate the response of the dispensing system 104 to oscillations. Vibrations of the motor induce oscillation to the body of dispensing system 104 which in turn generates fluid momentum within the chamber due to the dynamical interaction of the fluid with the solid structure of chamber 108. This phenomenon is often referred to as Solid-Fluid-Interaction (SFI). The momentum of the moving fluid exerts force that flexes the aperture plate 110 outwardly in the direction indicated by arrows 206a and 206b causing the aperture plate 110 to disengage from spherical member 114 thereby opening a fluid flow passage as indicated by the arrows 208a and 208b and ejection of fluid droplets 210.


Dispensing device 100 is supported by a flexible beam 122 or other structural embodiments which allows it to oscillate freely, as schematically shown by motion excursions 202 and 204. Preferably the spring constant of the beam 122 is 0.05 N/mm to 0.5 N/mm. For example, beam 122 can be formed by fabricating a slot 124 in support structure 120 such that the resulting beam 122 has a thickness suitable for providing a spring constant as recited above.



FIG. 3 illustrates an exemplary vibrational motor 302. The DC Motor 302 of this example has a cylindrical body with a diameter of 4 mm and total length of 17 mm. An eccentric flywheel 118 is attached to the motor shaft. The flywheel has a mass of 1.7 grams with a center of mass about 0.7 mm from the center of rotation. The motor receives 4.5-12 VDC and rotates at 6000-12000 RPM generating centrifugal force of 0.3N at a rotation speed of 8000 RPM. Other DC motors that generate centrifugal force of 0.1-1N and rotation speed of 1000-50000 RPM can be used. The motor can be controlled by a timer circuit which is set to provide an ON time as required to deliver a dose of 8-12 micro-liter. The actuation ON time is 60-200 ms depending on the rheology of the fluid in use. A timer circuit which incorporates a 555 timer IC or a microprocessor-based timer with a 12 volt battery such as A23 alkaline battery may be used.



FIGS. 4A-C illustrate an alternative preferred embodiment of dispensing system 400. FIG. 4A illustrates a frontal view and FIG. 4B illustrates a side view of dispensing system 400. Dispensing system 400 includes a concave mirror 402 which assists in aligning device 400 and fluid stream 210 to the eye of the user. In use, dispensing device 400 is positioned in front of the eye such that the image of the eye appears sharply and in the center of mirror to the user. At this point the device is properly positioned in term of the distance of the eye from the nozzle 404 and its angular orientation relative to the eye. Upon actuation, stream 210 will be deposited precisely on the corneal surface of the eye. Device 400 preferably includes a 0.22 micron air filter configured to filter the vented air that flows into device 400, as in the previous example.


Device 400 includes a check valve having an aperture plate 406 with a conical aperture 116 that extends through its thickness. The check valve further includes a spherical member 114 that tangentially engages with the inlet opening of the conical aperture 116. In this example, the check valve also includes a compression spring 408 configured to force aperture plate 406 against spherical member 114. In this way a tight seal is created along the engagement line 114a, thus creating a tight and hermetic closure.


Spherical member 114 can be partially covered with an antimicrobial coating, specifically in the area of spherical member 114 that is not in contact with fluid in the chamber. The coated area thus extends between the engagement line 114a and the outlet of the conical aperture (i.e., to the left of 114a on FIG. 4C)). Examples of antimicrobial coatings include silver in metallic form, silver alloy or a non-metallic material that contains silver including salts of silver chloride and silver sulfadiazine. Other optional material includes biguanide derivatives, chlorohexidine diacetate and chlorohexidine digluconate.



FIGS. 5A-B illustrate frontal and side views, respectively, of a dispensing device 400 packaged in a housing 502. Housing 502 provides a convenient enclosure to the dispensing system 400 that was described in relation in FIGS. 4A-C and is shown with dashed lines here. Housing 502 includes an electrical circuit (not shown) and a 12 volt battery (e.g., type A23) 506. The circuit controls the dispensing period such that a dose of 8-12 microliter is delivered to the ocular surface of the eye. Momentary switch 504 can be used to activate the device 400 such that a stream of droplets is ejected from the aperture as described earlier. FIGS. 5A-B also illustrate the mirror 402 which is visible on the front side of the device. Such a housing can also be used for a dispensing device 100 as described above.



FIGS. 6A-B illustrate some preferred features of housings that can be used with embodiments such as device 100 and device 400 as described above. In this example, the housing includes a swivel cover 602 that covers dispensing nozzle 606 during periods of non-use. Swivel cover 602 provides a means to prevent bacterial contamination on the external areas where a residual fluid may be left following each use. Such residual fluid may contaminate subsequent stream as it is dispensed through the nozzle. Swivel cover 602 preferably includes a flexible member 604 that includes a surface 604a that is covered with antimicrobial coating. Surface 604a engages with the outlet opening of nozzle 606 when the swivel cover 602 is closed as illustrated in FIG. 6B. In this way antipathogen action is achieved. Alternatively, organic dyes with antiseptic action may also be used. For example, toluidine blue, methylene blue, gentian violet and acridine and related active substances such as acridine orange and acridine yellow as well as ethacridine lactate. Germicidal polymers such as polyhexanide are also possible. Materials that contain additives which contain metal-organic substances with an ionizing effect can also be used. Such additives are available from SteriOne GmbH Berlin, Germany. Examples of antimicrobial coatings that can be used on surface 604a include silver in metallic form, silver alloy or a non-metallic material that contains silver including salt of silver chloride and silver sulfadiazine. Other optional material includes biguanide derivatives, chlorohexidine diacetate and chlorohexidine digluconate.



FIGS. 7A-B illustrate a dispensing system 700 utilizing an alternative fluid reservoir 702 configured to eliminate the need for venting and air filtering as previously described in relation to other embodiments. Dispensing system 700 includes a collapsible fluid chamber (e.g., a bellows) 702 containing ophthalmic solution to be dispensed. When fluid is dispensed the internal pressure inside the bellows 702 is gradually reduced which results in axial deformation of bellows 702 which in turn equalizes the pressure inside bellows 702 with the atmospheric pressure. In this way fluid inside the bellows 702 does not need to be vented to the atmosphere and further may not have to be in contact with air and particularly oxygen. Such a system is particularly advantageous for ophthalmic fluids that are sensitive to oxidation. Dispensing system 700 further includes cap 710 that seals off the dispensing nozzle during non-use period. FIG. 7B illustrates a frontal view of cap 710. It can be seen that cap 710 has an internal thread 714 that engages with the external thread 706. Cap 710 further includes a central pin 712 that is configured to seal off dispensing aperture 708 during periods of non-use. Apparatus 700 includes a flexible mount 704 to permit a vibration motor to vibrate the apparatus to eject liquid as described above.



FIG. 8A illustrates a cross-sectional view of the dispensing system of this example when bellows 702 is filled with fluid while FIG. 8B shows the bellows 702 in a collapsed or nearly empty state. It can be seen that the open end of bellows 702 is connected to the dispensing chamber 804. Preferably the sealed end of the bellows is recessed inwardly toward the bellows forming a cup-shaped indentation 802 as shown. In this way the unused volume that is left in bellows 702 once it is fully collapsed is minimized, as shown on FIG. 8B. Here stationary member 806 and flexible aperture plate 808 form a check value that operates as described above when the apparatus is vibrated by a vibration motor.

Claims
  • 1. An apparatus for delivering a liquid to an eye of a patient, the apparatus comprising: a) a collapsible reservoir configured to contain the liquid;b) a liquid dispenser, in fluid communication with the collapsible reservoir, and having a check valve and an actuator, the actuator including a vibration motor having an eccentric mechanical load relative to an axis of rotation of the vibration motor;c) wherein the check valve includes an aperture through which the liquid can be dispensed and a pin member that engages the aperture to define a normally closed configuration of the check valve; andd) wherein the actuator is configured to induce vibrations in the liquid dispenser to generate fluid momentum in the liquid contained within the liquid dispenser such that the liquid i) deforms the aperture to open the check valve to disengage the pin from the aperture; and ii) ejects the liquid through the aperture.
  • 2. The apparatus of claim 1, wherein the liquid dispenser is supported by a flexible member, whereby operation of the vibration motor generates the fluid momentum of the liquid by oscillating the liquid dispenser.
  • 3. The apparatus of claim 2, wherein a spring constant of the flexible member is between 0.05 N/mm and 0.5 N/mm.
  • 4. The apparatus of claim 1, wherein the aperture has a Young's modulus of elasticity between 0.5 GPa and 2 GPa.
  • 5. The apparatus of claim 4, wherein a mechanical hardness of the pin member is greater than a mechanical hardness of the aperture.
  • 6. The apparatus of claim 1, wherein the aperture is tapered to be narrower at an outlet of the aperture than at an inlet of the aperture.
  • 7. The apparatus of claim 1, wherein the pin member is stationary relative to the liquid dispenser.
  • 8. The apparatus of claim 1, wherein a tip of the pin member engages with the aperture, and wherein the tip of the pin member has a spherical shape.
  • 9. The apparatus of claim 8, wherein the tip of the pin member is partially or completely coated with an antibacterial coating.
  • 10. The apparatus of claim 9, wherein the antibacterial coating covers at least a part of the tip of the pin member that is outside the liquid dispenser in the normally closed configuration of the check valve.
  • 11. The apparatus of claim 1, wherein a preload force engaging the pin member with the aperture in the normally closed configuration of the check valve is between 0.01 N and 0.05 N.
  • 12. The apparatus of claim 1, wherein the collapsible reservoir does not include a vent.
  • 13. The apparatus of claim 1, further comprising a concave mirror configured to provide an in-focus image of the eye of the patient to the patient when the apparatus is positioned properly to deliver the liquid to the eye of the patient.
  • 14. A fluid ejecting device, the device comprising, a collapsible reservoir designed to receive a fluid and a housing configured to receive the fluid to be ejected;a check valve including an aperture defined within the housing and a pin fixed to the housing, the aperture being deformable to define i) a closed configuration such that the aperture receives at least a portion of the pin, and ii) an open configuration where the pin is disengaged from the aperture; andan actuator connected to the housing and configured to induce vibrations to the housing to generate fluid momentum in the fluid contained within the housing such that the fluid i) elastically deforms the aperture to the open configuration such that the pin disengages from the aperture and fluid flows through the aperture, the actuator including a vibration motor having an eccentric mechanical load relative to an axis of rotation of the vibration motor.
  • 15. The device of claim 14, further comprising a concave mirror configured to provide an in-focus image of a patient's eye to a patient when the device is positioned properly to deliver the fluid to the eye of the patient.
  • 16. The device of claim 14, wherein a tip of the pin is engaged with the aperture, and wherein the tip of the pin has a spherical shape.
  • 17. The device of claim 16, wherein the tip of the pin is partially or completely coated with an antibacterial coating.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. provisional patent application 63/011,808, filed on Apr. 17, 2020, and hereby incorporated by reference in its entirety. This application claims the benefit of U.S. provisional patent application 63/166,754, filed on Mar. 26, 2021, and hereby incorporated by reference in its entirety.

US Referenced Citations (292)
Number Name Date Kind
3598121 Lelicoff Aug 1971 A
3640274 Costello Feb 1972 A
3779245 Windsor Dec 1973 A
3812854 Buckles May 1974 A
3861386 Harris Jan 1975 A
3934585 Maurice Jan 1976 A
3970250 Drews Jul 1976 A
3976072 Walker Aug 1976 A
4159803 Cameto Jul 1979 A
4300546 Kruber Nov 1981 A
4334531 Reichl Jun 1982 A
4338576 Takahashi Jul 1982 A
4344744 Schuster et al. Aug 1982 A
4352459 Berger Oct 1982 A
4465234 Maehara Aug 1984 A
4632311 Nakane Dec 1986 A
4655393 Berger Apr 1987 A
4793339 Matsumoto et al. Dec 1988 A
4850534 Takahashi Jul 1989 A
4882150 Kaufman Nov 1989 A
4952581 Bito Aug 1990 A
4961345 Tsuruoka Oct 1990 A
4976259 Higson Dec 1990 A
4981625 Rhim Jan 1991 A
5025957 Ranalletta Jun 1991 A
5171306 Vo Dec 1992 A
5232363 Meller Aug 1993 A
5368582 Bertera Nov 1994 A
5370317 Weston Dec 1994 A
5487378 Robertson Jan 1996 A
5549249 Foster Aug 1996 A
5624057 Lifshey Apr 1997 A
5627611 Scheiner May 1997 A
5630793 Rowe May 1997 A
5657926 Toda Aug 1997 A
5692651 Fuchs Dec 1997 A
5811443 DeSantis, Jr. Sep 1998 A
5828394 Khuri-Yakub et al. Oct 1998 A
5938117 Ivri Aug 1999 A
5958342 Gamble Sep 1999 A
5960224 Sanada et al. Sep 1999 A
6024717 Ball Feb 2000 A
6062212 Davison May 2000 A
6065623 Hierzer May 2000 A
6095376 Hennemann Aug 2000 A
6196218 Voges Mar 2001 B1
6232129 Wiktor May 2001 B1
6273092 Nolan Aug 2001 B1
6302101 Py Oct 2001 B1
6467476 Ivri Oct 2002 B1
RE38077 Cohen Apr 2003 E
6543442 Gonda Apr 2003 B2
6629646 Ivri Oct 2003 B1
6730066 Bennwik May 2004 B1
6758837 Peclat Jul 2004 B2
6869275 Dante et al. Mar 2005 B2
7066398 Borland Jun 2006 B2
7105357 Kalkum Sep 2006 B1
7201732 Anderson Apr 2007 B2
7314938 Shen Jan 2008 B2
7571722 Wuttke Aug 2009 B2
7745460 Shen Jun 2010 B2
7790743 Shen Sep 2010 B2
7874467 Pardes Jan 2011 B2
7883031 Collins, Jr. Feb 2011 B2
7928122 Shen Apr 2011 B2
8012136 Collins, Jr. Sep 2011 B2
8048047 Domash Nov 2011 B2
8056766 Grevin Nov 2011 B2
8128606 Anderson Mar 2012 B2
8133210 Al-Abdulla Mar 2012 B2
8144399 Steenblik Mar 2012 B2
8168655 Gadek May 2012 B2
8273307 Eickhoff Sep 2012 B2
8367701 Burnier Feb 2013 B2
8398001 Borland Mar 2013 B2
8435544 Mitra May 2013 B2
8544462 Papania Oct 2013 B2
8545463 Collins, Jr. Oct 2013 B2
8592450 Gadek Nov 2013 B2
8629111 Acheampong Jan 2014 B2
8633162 Acheampong Jan 2014 B2
8642556 Acheampong Feb 2014 B2
8648048 Acheampong Feb 2014 B2
8684980 Hunter Apr 2014 B2
8685930 Acheampong Apr 2014 B2
8722728 Wong May 2014 B2
8733935 Ballou, Jr. May 2014 B2
8863998 Painchaud Oct 2014 B2
8927574 Burnier Jan 2015 B2
8927921 Nelms Jan 2015 B1
8936021 Collins, Jr. Jan 2015 B2
9039666 Voss May 2015 B2
9068566 Ivri Jun 2015 B2
9085553 Zeller Jul 2015 B2
9087145 Ballou, Jr. Jul 2015 B2
9186690 Scanlon Nov 2015 B2
9216174 Shen Dec 2015 B2
9238532 Decock Jan 2016 B2
9248191 Acheampong Feb 2016 B2
9353088 Burnier May 2016 B2
9447077 Burnier Sep 2016 B2
9597230 Haffner Mar 2017 B2
9676525 Greiner-Perth Jun 2017 B2
9700686 Gavini Jul 2017 B2
9801757 Voss Oct 2017 B2
9808825 Aguilar Nov 2017 B2
9867933 Pardes Jan 2018 B2
9890141 Burnier Feb 2018 B2
10073949 Ballou, Jr. Sep 2018 B2
10105720 Decock et al. Oct 2018 B2
10124000 Shen Nov 2018 B2
10154923 Hunter Dec 2018 B2
10174017 deLong Jan 2019 B2
10314740 Kraft Jun 2019 B2
10624781 Ivri Apr 2020 B2
11278448 Palanker Mar 2022 B2
20010035184 Schuler et al. Nov 2001 A1
20010036424 Takahashi Nov 2001 A1
20010036449 Garst Nov 2001 A1
20020078947 Gumaste Jun 2002 A1
20020124843 Skiba Sep 2002 A1
20020158196 Berggren Oct 2002 A1
20020161344 Peclat Oct 2002 A1
20020185125 Klimowicz Dec 2002 A1
20020190079 Hamamoto Dec 2002 A1
20030052573 Wischnewskiy Mar 2003 A1
20030065294 Pickup Apr 2003 A1
20030071071 Garcia Apr 2003 A1
20030140921 Smith Jul 2003 A1
20040039355 Gonzalez Feb 2004 A1
20040050861 Lisec Mar 2004 A1
20040138630 Al-Abdulla Jul 2004 A1
20040163645 Connelly Aug 2004 A1
20040173642 Clifford Sep 2004 A1
20040204674 Anderson Oct 2004 A1
20040215157 Peclat Oct 2004 A1
20040256487 Collins Dec 2004 A1
20040263567 Hess et al. Dec 2004 A1
20050001981 Anderson Jan 2005 A1
20050006417 Nicol Jan 2005 A1
20050107832 Bernabei May 2005 A1
20050172962 Gumaste Aug 2005 A1
20050207917 Koerner et al. Sep 2005 A1
20050240162 Chen Oct 2005 A1
20050261641 Warchol Nov 2005 A1
20060065677 Py Mar 2006 A1
20060069358 Gerondale Mar 2006 A1
20060147313 Zengerle Jul 2006 A1
20060210604 Dadey et al. Sep 2006 A1
20070051362 Sullivan Mar 2007 A1
20070088267 Shekalim Apr 2007 A1
20070088268 Edwards Apr 2007 A1
20070102455 Stark May 2007 A1
20070119969 Collins, Jr. et al. May 2007 A1
20070195151 Anderson Aug 2007 A1
20070268340 Dacquay Nov 2007 A1
20070295332 Ziegler et al. Dec 2007 A1
20080039807 Pine Feb 2008 A1
20080202514 Kriksunov Aug 2008 A1
20080214940 Benaron Sep 2008 A1
20080233053 Gross Sep 2008 A1
20080247264 Gabl Oct 2008 A1
20080257911 Choi Oct 2008 A1
20090060793 Eickhoff Mar 2009 A1
20090114742 Collins, Jr. May 2009 A1
20090134235 Ivri May 2009 A1
20090182291 Eilat Jul 2009 A1
20090192443 Collins, Jr. Jul 2009 A1
20090212127 Reynolds Aug 2009 A1
20090212133 Collins, Jr. Aug 2009 A1
20090223513 Papania Sep 2009 A1
20100001090 Neergaard Jan 2010 A1
20100005903 Beavis Jan 2010 A1
20100013352 Pletner Jan 2010 A1
20100044460 Sauzade Feb 2010 A1
20100072301 Cater Mar 2010 A1
20100072302 Cater Mar 2010 A1
20100076388 Cater Mar 2010 A1
20100147899 Nardi Jun 2010 A1
20100186738 Kobayashi et al. Jul 2010 A1
20100222752 Collins, Jr. Sep 2010 A1
20100236545 Kern Sep 2010 A1
20100295420 Wierach Nov 2010 A1
20100326431 Yu Dec 2010 A1
20110074247 Hohlfeld Mar 2011 A1
20110102735 Gupta May 2011 A1
20110106025 Hall May 2011 A1
20110146670 Gallem et al. Jun 2011 A1
20110284579 Pardes Nov 2011 A1
20110293452 Kim Dec 2011 A1
20110305425 Fabrykowski et al. Dec 2011 A1
20120017898 Moller Jan 2012 A1
20120062840 Ballou, Jr. Mar 2012 A1
20120070467 Ballou, Jr. Mar 2012 A1
20120143152 Hunter Jun 2012 A1
20120179122 Eilat Jul 2012 A1
20120197219 Scanlon Aug 2012 A1
20120304929 Ivri Dec 2012 A1
20130002095 Van der Linden Jan 2013 A1
20130017283 Zemel Jan 2013 A1
20130025038 Frey Jan 2013 A1
20130053042 Tanikawa Feb 2013 A1
20130079733 Burt et al. Mar 2013 A1
20130118619 Loth May 2013 A1
20130140225 Decock Jun 2013 A1
20130150812 Hunter Jun 2013 A1
20130152796 Pawl Jun 2013 A1
20130153677 Leen Jun 2013 A1
20130164436 Yagi et al. Jun 2013 A1
20130172830 Hunter Jul 2013 A1
20130206857 Ivri Aug 2013 A1
20130299607 Wilkerson Nov 2013 A1
20130345672 Ferreri Dec 2013 A1
20140088524 Marx Mar 2014 A1
20140113946 Abad Apr 2014 A1
20140157956 Date Jun 2014 A1
20140171490 Gross Jun 2014 A1
20140187969 Hunter Jul 2014 A1
20140214024 Eichler Jul 2014 A1
20140224267 Levitz Aug 2014 A1
20140242022 Vehige Aug 2014 A1
20140249491 Ballou, Jr. Sep 2014 A1
20140257172 Yalamanchili Sep 2014 A1
20140274910 Cumberlidge Sep 2014 A1
20140276054 Hossack Sep 2014 A1
20140285121 Balogh Sep 2014 A1
20140323931 Avni Oct 2014 A1
20140336596 Wochele Nov 2014 A1
20140336618 Wilkerson Nov 2014 A1
20150018781 Rinderknect Jan 2015 A1
20150035180 Shen Feb 2015 A1
20150036219 Shen Feb 2015 A1
20150086397 Ma Mar 2015 A1
20150097050 Ciervo Apr 2015 A1
20150139973 Steinfeld May 2015 A1
20150144128 Hijlkema May 2015 A1
20150209174 Abreu Jul 2015 A1
20150209178 Blakey Jul 2015 A1
20150238689 Shimizu Aug 2015 A1
20150256730 Shen Sep 2015 A1
20150276994 Shen Oct 2015 A1
20150308421 Vogt Oct 2015 A1
20150328151 Ballou, Jr. Nov 2015 A1
20150352297 Stedman Dec 2015 A1
20160107180 Decock et al. Apr 2016 A1
20160120833 Wan May 2016 A1
20160129467 Ciardella May 2016 A1
20160199225 Ivri Jul 2016 A1
20160199230 Doshi Jul 2016 A1
20160213866 Tan Jul 2016 A1
20160263314 Pardes Sep 2016 A1
20160296367 Ivri Oct 2016 A1
20160354559 Gavini Dec 2016 A1
20170028626 Delrot Feb 2017 A1
20170136484 Wilkerson May 2017 A1
20170138357 Kondo et al. May 2017 A1
20170151088 Ballou, Jr. Jun 2017 A1
20170156927 Richter Jun 2017 A1
20170182510 Wilkerson Jun 2017 A1
20170187969 Kitamori Jun 2017 A1
20170274159 Gavini Sep 2017 A1
20170344714 Ballou, Jr. Nov 2017 A1
20180085251 Hunter Mar 2018 A1
20180108275 Newberry Apr 2018 A1
20180116871 Hunter May 2018 A1
20180207030 Ivri et al. Jul 2018 A1
20180229247 Laidler Aug 2018 A1
20180236466 Laidler Aug 2018 A1
20180297053 Buckland Oct 2018 A1
20190053945 Hunter Feb 2019 A1
20190074086 Ballou, Jr. Mar 2019 A1
20190099071 Ehrmann Apr 2019 A1
20190314195 Ivri Oct 2019 A1
20190314196 Ivri Oct 2019 A1
20190314197 Ivri Oct 2019 A1
20190314198 Ivri Oct 2019 A1
20200022416 Alarcon Jan 2020 A1
20200197218 Newell Jun 2020 A1
20200197220 Ivri Jun 2020 A1
20200246182 Ivri Aug 2020 A1
20200281768 Quintana Sep 2020 A1
20200315842 Palanker Oct 2020 A1
20200330267 Li Oct 2020 A1
20210128350 Ivri May 2021 A1
20210137732 Quintana May 2021 A1
20210220169 Ivri Jul 2021 A1
20210322209 Ivri Oct 2021 A1
20220039998 Ivri Feb 2022 A1
20220125631 Ianchulev Apr 2022 A1
20220160542 Palanker May 2022 A1
20220192874 Ivri Jun 2022 A1
Foreign Referenced Citations (33)
Number Date Country
103118642 May 2013 CN
104146816 Nov 2014 CN
104582647 Apr 2015 CN
204813955 Dec 2015 CN
105351426 Feb 2016 CN
107530509 Jan 2018 CN
0622035 Nov 1994 EP
0622035 Mar 1999 EP
1493410 Jan 2005 EP
H08251948 Sep 1996 JP
3055480 Jan 1999 JP
2007531577 Nov 2007 JP
2013535250 Sep 2013 JP
10-1258025 Apr 2013 KR
10-2013-0054352 May 2013 KR
1994020875 Jan 1995 WO
WO-9600050 Jan 1996 WO
2000005482 Feb 2000 WO
2001046134 Jun 2001 WO
WO-02072169 Sep 2002 WO
2010078428 Jul 2010 WO
2012009706 Jan 2012 WO
2013076682 May 2013 WO
2013090459 Jun 2013 WO
2013090468 Jun 2013 WO
2013155201 Oct 2013 WO
2013158967 Dec 2013 WO
2016115050 Jul 2016 WO
2016164830 Oct 2016 WO
2018136618 Jul 2018 WO
2018227190 Dec 2018 WO
2019113483 Jun 2019 WO
2020010116 Jan 2020 WO
Non-Patent Literature Citations (28)
Entry
Abidi et al., “Lifilegrast: A Novel Drug for Treatment of Dry Eye Disease”, Journal of Pharmacology and Pharmacotherapy, 2016, vol. 7, pp. 194-198.
Ali et al., “Glaucoma and Dry Eye”, Ophthalmology, 2009, vol. 116, p. 1232.
Birkhoff et al., “New Devices for Dispensing Ophthalmic Treatments May Be the Key to Managing the Life Cycles of Established Products”, 2010, Drug Delivery Technology, vol. 10, pp. 16-21.
Brenton, “CRUK/10/30: TRICON8—Sample collection of ovarian cancer tissues and blood for translational research from patients participating in the CR-UK/MRC ICON8 trial”, 2015, online abstract.
Choi et al., “Generation of Controllable Monodispersed Sprays Using Impulse Jet and Charging Techniques”, Review of Scientific Instruments, 1990, vol. 61, pp. 1689-1693.
Denion et al., “A 5-Minute Interval between Two Dilating Eye Drops Increases Their Effect”, Jul. 19, 2017, Optometry and Vision Science, vol. 94, pp. 838-844.
Electronic Tutorials, “Linear Solenoid Actuator”, 2016 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet [URL: https://www.electronics-tutorials.ws/io/io_6.html].
Elert, Glenn, “Spherical mirrors”, The Physics Hypertextbook, 2021 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet [URL: https://physics.info/mirrors/].
Gannon, Megan, “The Best Length for Eyelashes, According to Science”, Feb. 24, 2015 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet [URL: https://www.livescience.com/49934-optimal-length-for-eyelashes-discovered.html].
Ianchulev et al., “Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper”, 2016, Ther. Deliv., vol. 7, pp. 751-760.
Jow et al., “Design and Optimization of Printed Spiral Coils for Efficient Transcutaneous Inductive Power Transmission”, IEEE Transactions on Biomedical Circuits and Systems, 2007, vol. 1, pp. 193-202.
Kent, Christopher, “Getting Meds onto the Eye, 21st Century Style”, Mar. 15, 2013 [online]; [Retrieved on Aug. 27, 2019], Retrieved from the Internet [URL: https://www.reviewofophthalmology.com/article/getting-meds-onto-the-eye-21st-century-style].
Kompella et al., “ISOPT Clinical Hot Topic Panel Discussion on Ocular Drug Delivery”, 2019, J. Ocul. Pharmacol. Ther., vol. 35, pp. 457-465.
Lallemand et al., “Cyclosporine A Delivery to the Eye: A Comprehensive Review of Academic and Industrial Efforts”, European Journal of Pharmaceutics and Biopharmaceutics, 2017, vol. 117, pp. 14-28.
Lindblad et al., “Production of Uniform-Sized Liquid Droplets”, Journal of Scientific Instruments, 1965, vol. 42, pp. 635-638.
Lux et al., “A Comparative Bioavailability Study of Three Conventional Eye Drops Versus a Single Lyophilisate”, Br. J. Ophthalmol., 2003, vol. 87, pp. 436-440.
Macmillan Online Dictionary, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018]; Retrieved from the Internet [URL: https://macmillandictionary.com/dictionary/american/stream_ 1#stream_9].
Merriam-Webster, “Clamp,” 2019 [online]; [Retrieved on Oct. 25, 2022], Retrieved from the Internet [URL: https://www.merriam-webster.com/dictionary/clamp].
Merriam-Webster, “Collimate,” 2020 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet [URL: https://www.merriam-webster.com/dictionary/collimated].
Merriam-Webster, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018], Retrieved from the Internet [URL: https://www.merriam-webster.com/dictionary/stream].
Murube et al., “Classification of Artificial Tears, I: Composition and Properties”, Advanced Experimental Medical Biology, 1998, vol. 438, pp. 693-704.
Murube et al., “Classification of Artificial Tears, Il: Additives and Commercial Formulas”, Advanced Experimental Medical Biology, 1998, vol. 438, pp. 705-715.
Oxford Online Dictionary, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018]; Retrieved from the Internet [URL: https://en.oxforddictionaries.com/definition/US/stream].
Pronin et al., “Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor”, 2017, Mol. Pharmacol., vol. 92, pp. 601-612.
Vocabulary.com, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018]; Retrieved from the Internet [URL: https://www.dictionary.com/stream].
Marx et al., “Opthalmic Squeeze Dispenser: Eliminating the Need for Additives in Multidose Preservative-Free Eyecare Formulations”, 2017, Drug Development & Delivery, vol. 17, pp. 40-44.
International Search Report and Written Opinion dated Jul. 16, 2021 in corresponding International Patent Application No. PCT/US2021/027773 (9 pages).
International Search Report and Written Opinion dated Jul. 16, 2021 in corresponding International Patent Application No. PCT/US2021/027779 (8 pages).
Related Publications (1)
Number Date Country
20210322210 A1 Oct 2021 US
Provisional Applications (2)
Number Date Country
63011808 Apr 2020 US
63166754 Mar 2021 US